Carbatrol Oral Capsule, Extended Release 100Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Carbatrol: Oral capsule, extended release (100mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_3476.JPG
Carbatrol 100mg ER Cap
Shire US Inc
Pill Identification: Shire CARBATROL 100mg 

What is this Medicine?

CARBAMAZEPINE (kar ba MAZ e peen) is used to control seizures caused by certain types of epilepsy. This medicine is also used to treat nerve related pain. It is not for common aches and pains.

CVS Pharmacy Patient Statistics for Carbatrol: Oral capsule, extended release(100mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Carbatrol 100mg Extended-Release Capsule

NDC: 540920171
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Trigeminal Neuralgia, Tonic-clonic Seizures, Neuropathic Pain, Partial Seizures

Storage Information
Protect from light
Protect from moisture
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Carbatrol 100mg Extended-Release Capsule
Drug Image file DrugItem_3476.JPG
Shire US Inc
Pill Identification: Shire CARBATROL 100mg 
Shape: capsule
Color: blue-green

Reported Side Effects for Carbatrol 100mg Extended-Release Capsule

Inflamed Brain Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Thoughts Of Suicide Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
High White Blood Cells Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
No White Blood Cells Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Drug Reaction With Eosinophilia And Systemic Symptoms (DRESS) Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Lyell'S Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Liver Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Eosinophilia Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Neuroleptic Malignant Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Aplastic Anemia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low Platelet Count Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Lightheadedness Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Paresthesias Incidence:
2.0%*
Severity: MILD
Onset: DELAYED
Balance Problems Incidence:
2.0%*
Severity: MILD
Onset: EARLY
High Blood Pressure Incidence:
3.0%*
Severity: MODERATE
Onset: EARLY
Shaking Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Blurred Vision Incidence:
6.0%*
Severity: MODERATE
Onset: EARLY
Skin Rash Incidence:
7.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
8.0%*
Severity: MILD
Onset: RAPID
Weakness Incidence:
8.0%*
Severity: MILD
Onset: DELAYED
Dry Mouth Incidence:
8.0%*
Severity: MILD
Onset: EARLY
Incoordination Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Drowsiness Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
10.0%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Carbatrol 100mg Extended-Release Capsule

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Alcohol and Carbatrol 100mg Extended-Release Capsule(Carbamazepine)
Alcohol and Carbamazepine (Systemic)(Carbamazepine)
You should avoid alcoholic beverages while taking Carbamazepine. Alcohol can affect seizure control and interfere with the drug treatment, and may increase the risk of serious side effects. Decreased alertness, drowsiness, falls, or other side effects may occur. Do not drive or operate machinery if you are drinking alcohol-containing beverages. If you notice slurred speech, confusion, severe weakness, or difficulty breathing, contact your health care provider immediately.
Moderate Lifestyle Interaction
Enteral Feedings and Carbatrol 100mg Extended-Release Capsule(Carbamazepine)
Enteral Feedings and Carbamazepine(Carbamazepine)
Enteral feedings may decrease the actions of Carbamazepine oral suspension. To avoid an interaction with liquid nutrition products, take Carbamazepine oral suspension at least 15 minutes before or 15 minutes after you take tube feedings or nutritional supplement beverages (examples: Ensure, Jevity, and others). Enteral feedings do not appear to interact with Carbamazepine tablets or capsules.
Moderate Lifestyle Interaction
Grapefruit juice and Carbatrol 100mg Extended-Release Capsule(Carbamazepine)
Grapefruit juice and Carbamazepine (Systemic)(Carbamazepine)
Grapefruit juice and grapefruit-containing foods may increase the effects of Carbamazepine. Do not significantly alter your intake of grapefruit juice while taking this drug.
Moderate Lifestyle Interaction
Marijuana and Carbatrol 100mg Extended-Release Capsule(Carbamazepine)
Marijuana and Carbamazepine (Systemic)(Carbamazepine)
Carbamazepine can theoretically increase the elimination of Marijuana, Medical from the body. The side effect profile of Marijuana, Medical may be altered if you take Carbamazepine. You may feel drowsy or more tired. Do not drive or operate machinery until you know how these drugs affect you. Contact your health care provider immediately if you notice slurred speech, confusion, increases heart rate, or palpitations while taking Marijuana, Medical.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More